Leapwork recently released new research showing that while confidence in AI-driven software testing is growing rapidly, accuracy, stability, and ongoing manual effort remain decisive factors in how ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune ...
The Plant Base is the go to B2B news platform for the plant-based food and beverage industry. Refreshment is your ultimate resource for staying informed and up-to-date on the water cooler, vending, ...
Ethiopia’s Farmer-Led Irrigation Development (FLID) program marks a shift from top-down irrigation to farmer ownership. Backed by the World Bank through the Food Systems Resilience Program, FLID ...
LAS VEGAS, Jan 6 (Reuters) - Amazon's cloud unit has partnered with German automotive hardware supplier Aumovio to support the commercial rollout of self-driving vehicles, starting with Aurora's ...
AI-powered platform to predict patient safety and efficacy profiles, unlocking precision-driven oncology development BostonGene, the developer of the leading AI foundation model for tumor and immune ...
Northrop Grumman test-fired a solid rocket motor called SMASH!22 Dec. 4 as part of its SMART Demo development program. Credit: Northrop Grumman WASHINGTON — Northrop Grumman tested a solid rocket ...
Amazon Web Services Inc. today introduced a new feature for Kiro, the company’s artificial intelligence-powered agentic coding environment for software developers, adding new “powers” that bring ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Biotech is booming in China, and that’s no accident. While the most closely tracked U.S. index of biotech stocks is up more than 20% this year, Chinese biotech stocks are doing even better, staging a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results